DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.
Lancet Neurol 2017;
16 (11) 925-933
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.